Content about Peripheral membrane proteins

January 7, 2013
Biogen Idec hopes treatment will be first advance in hemophilia B treatment in 15 years

Biogen Idec is seeking Food and Drug Administration approval for a hemophilia drug that it called the first of its kind.

December 21, 2010
Biogen acquires rights to neuro disease programs

In a deal that will bolster its drug development capabilities, Biogen Idec has acquired a subsidiary of Swiss-based Neurimmune Holding AG.

October 31, 2010
Octapharma USA starts phase 3 trial for hemophilia treatment

The U.S. subsidiary of a Swiss biotech company has started a late-stage trial of a...

© 2013 Drug Store News. All Rights Reserved.